These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 32914205)

  • 1. Study on the Mechanisms of Banxia Xiexin Decoction in Treating Diabetic Gastroparesis Based on Network Pharmacology.
    Wu T; Yue R; Li L; He M
    Interdiscip Sci; 2020 Dec; 12(4):487-498. PubMed ID: 32914205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Banxia Xiexin Decoction () Treats Diabetic Gastroparesis through PLC-IP
    Wang B; Zeng KW; Hong ZF; Ti GX; Wang LY; Lu P; Liu Z
    Chin J Integr Med; 2020 Nov; 26(11):833-838. PubMed ID: 32418177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the therapeutic mechanism of Banxia Xiexin Decoction in mild cognitive impairment and diabetes mellitus: a network pharmacology approach.
    Li C; Yang W; Meng Y; Feng L; Sun L; Li Z; Liu X; Li M
    Metab Brain Dis; 2023 Oct; 38(7):2315-2325. PubMed ID: 37556042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying the active compounds and mechanism of action of Banxia Xiexin decoction for treating ethanol-induced chronic gastritis using network pharmacology combined with UPLC-LTQ-Orbitrap MS.
    Ji W; Wang T; Xu Y; An R; Liang K; Wang X
    Comput Biol Chem; 2021 Aug; 93():107535. PubMed ID: 34217946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Potential molecular mechanism of Banxia Xiexin Decoction in treatment of colon cancer based on network pharmacology and molecular docking technology].
    Luo YT; Lin LF; Liu YL; Shi GL; Wu YQ; Yang AH; Li H
    Zhongguo Zhong Yao Za Zhi; 2020 Dec; 45(23):5753-5761. PubMed ID: 33496116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects and Components of Herb Pair Huanglian-Banxia on Diabetic Gastroparesis by Network Pharmacology.
    Liang G; Zhang L; Jiang G; Chen X; Zong Y; Wang F
    Biomed Res Int; 2021; 2021():8257937. PubMed ID: 34708128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploration of the potential mechanism of Banxia Xiexin Decoction for the effects on TNBS-induced ulcerative colitis rats with the assistance of network pharmacology analysis.
    Wang W; Xu C; Li X; Wang Z; Yang J; Shen Y; Shi M; Chen L; Zhang L; Guo Y; Wang B; Zhang T; Pu Y
    J Ethnopharmacol; 2021 Sep; 277():114197. PubMed ID: 34004261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the pharmacological mechanism of Banxia Xiexin decoction in treating depression and ulcerative colitis based on a biological network module.
    Yu Y; Zhang G; Han T; Huang H
    BMC Complement Med Ther; 2020 Jun; 20(1):199. PubMed ID: 32600331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the multicomponent synergy mechanism of Banxia Xiexin Decoction on irritable bowel syndrome by a systems pharmacology strategy.
    Li B; Rui J; Ding X; Yang X
    J Ethnopharmacol; 2019 Apr; 233():158-168. PubMed ID: 30590198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect and mechanism of Banxia Xiexin decoction in colorectal cancer: A network pharmacology approach.
    Wang Y; Zhao T; Huang C; Liu F; Zhang Y; Kong D; Fan Z
    Phytomedicine; 2024 Jan; 123():155174. PubMed ID: 38039904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Banxia Xiexin decoction ameliorates dextran sulfate sodium (DSS)-induced ulcerative colitis via inhibiting serine-threonine protein kinase (Akt)/mitogen-activated protein kinase (MAPK) signaling pathway.
    Ji W; Liu W; Huo Y; Hu C; Zhang Y
    Biotechnol Appl Biochem; 2023 Aug; 70(4):1530-1542. PubMed ID: 36806191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the Underlying Mechanism of
    Zheng X; Zhang Y; Xu J; Li X; Wen H; Zhang X; Liu A; Zhang J
    Front Biosci (Landmark Ed); 2023 Aug; 28(8):164. PubMed ID: 37664921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of Molecular Mechanism of Banxia Xiexin Decoction in Colon Cancer via Network Pharmacology and
    Ma L; Fang X; Yin X; Li Y
    Evid Based Complement Alternat Med; 2022; 2022():4961407. PubMed ID: 35815259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioactive components of Banxia Xiexin Decoction for the treatment of gastrointestinal diseases based on flavor-oriented analysis.
    Wang W; Gu W; He C; Zhang T; Shen Y; Pu Y
    J Ethnopharmacol; 2022 Jun; 291():115085. PubMed ID: 35150814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness and safety of traditional Chinese medicine decoction for diabetic gastroparesis: A network meta-analysis.
    Zhang YX; Zhang YJ; Miao RY; Fang XY; Wei JH; Wei Y; Lin JR; Tian JX
    World J Diabetes; 2023 Mar; 14(3):313-342. PubMed ID: 37035221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of potential bioactive compounds and mechanisms of GegenQinlian decoction on improving insulin resistance in adipose, liver, and muscle tissue by integrating system pharmacology and bioinformatics analysis.
    Cao Z; Zeng Z; Wang B; Liu C; Liu C; Wang Z; Li S
    J Ethnopharmacol; 2021 Jan; 264():113289. PubMed ID: 32846191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of Banxia Xiexin Decoction Underlying Chronic Atrophic Gastritis via Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulations.
    Chang C; Feng W; Sun M; Yu X; Sun Z
    Comput Math Methods Med; 2022; 2022():4237040. PubMed ID: 36158124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elucidation of the Mechanisms and Molecular Targets of
    Xu M; Li Z; Yang L; Zhai W; Wei N; Zhang Q; Chao B; Huang S; Cui H
    Biomed Res Int; 2020; 2020():5848497. PubMed ID: 32851081
    [No Abstract]   [Full Text] [Related]  

  • 19. Banxia xiexin decoction protects against dextran sulfate sodium-induced chronic ulcerative colitis in mice.
    Chen G; Yang Y; Liu M; Teng Z; Ye J; Xu Y; Cai X; Cheng X; Yang J; Hu C; Wang M; Cao P
    J Ethnopharmacol; 2015 May; 166():149-56. PubMed ID: 25794808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the bioactive components of Banxia Xiexin Decoction that protect against CPT-11-induced intestinal toxicity via UPLC-based spectrum-effect relationship analyses.
    Shi JW; Li ZZ; Wu JS; Jin WY; Chang XY; Sun H; Dong L; Jiang ZP; Shi Y
    J Ethnopharmacol; 2021 Feb; 266():113421. PubMed ID: 33022337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.